Grifols S.A.
Develops and produces plasma-derived medicines and biopharmaceutical solutions.
GRF | MC
Overview
Corporate Details
- ISIN(s):
- ES0171996087 (+4 more)
- LEI:
- 959800HSSNXWRKBK4N60
- Country:
- Spain
- Address:
- Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
- Website:
- https://www.grifols.com/en/home
- Sector:
- Manufacturing
Description
Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-19 19:02 |
Grifols informa que el Consejo de Administración no recomendaría a los accionis…
|
Spanish | 39.8 KB | ||
| 2024-11-19 12:11 |
En relación con la nota de información privilegiada enviada hoy a la CNMV por B…
|
Spanish | 40.4 KB | ||
| 2024-11-19 12:02 |
Brookfield Capital Partners UK Limited comunica información sobre noticias publ…
|
Spanish | 8.6 KB | ||
| 2024-11-07 17:38 |
Presentación de Resultados y nota de prensa del tercer trimestre
|
Spanish | 985.9 KB | ||
| 2024-09-25 18:21 |
Grifols informa ha recibido de la CNMV la comunicación de que su Comité Ejecuti…
|
Spanish | 90.7 KB | ||
| 2024-09-23 08:31 |
El Consejo de Administración de Grifols ha acordado que D. Thomas Glanzmann pas…
|
Spanish | 44.3 KB | ||
| 2024-07-30 16:21 |
La CNMV ha decidido levantar la suspensión de Grifols, S.A. con efecto de las 1…
|
Spanish | 156.7 KB | ||
| 2024-07-30 16:01 |
Grifols anuncia los resultados financieros del segundo trimestre de 2024
|
Spanish | 680.8 KB | ||
| 2024-07-19 21:19 |
Designación de asesores financieros de los consejeros no conflictuados y del Co…
|
Spanish | 106.6 KB | ||
| 2024-07-16 17:38 |
Reorganización del Consejo y Comisiones.
|
Spanish | 99.2 KB | ||
| 2024-07-12 18:36 |
Otra información relevante.
|
Spanish | 100.6 KB | ||
| 2024-07-08 11:33 |
La CNMV ha decidido levantar la suspensión de la negociación de GRIFOLS, S.A. c…
|
Spanish | 147.2 KB | ||
| 2024-07-04 11:59 |
Grifols quiere informar que el Sr. Rahul Srinivasan será el nuevo Chief Financi…
|
Spanish | 40.7 KB | ||
| 2024-07-03 13:28 |
Grifols informa que los fondos obtenidos con motivo de la transacción de SRAAS …
|
Spanish | 39.5 KB | ||
| 2024-06-27 18:32 |
Otra información relevante.
|
English | 107.4 KB |
Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Grifols S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Grifols S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
